Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up (Q57259766)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up |
article |
Statements
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up (English)
0 references
May 2002
0 references
16
0 references
7
0 references
1051-1058
0 references